MWVC
ELV icon

Morgens Waterfall Vintiadis & Co’s Elevance Health ELV Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,100
Closed -$1.41M – 43
2022
Q3 		$1.41M Buy
+3,100
New +$1.48M 1.54% 21
2019
Q2 		– Sell
-7,100
Closed -$2.04M – 62
2019
Q1 		$2.04M Buy
+7,100
New +$2.05M 1.46% 29

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's ELV Position: Q4 2022 in Review

Morgens Waterfall Vintiadis & Co sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 3,100 shares — an estimated $1.41M sold.

Morgens Waterfall Vintiadis & Co first reported a position in ELV in Q1 2019 and held it in 2 quarters. The position peaked at $2.04M in Q1 2019. 1,549 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • Morgens Waterfall Vintiadis & Co reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 3,100 Elevance Health shares in Q4 2022, an estimated $1.41M.
  • Morgens Waterfall Vintiadis & Co first reported a position in Elevance Health in Q1 2019 and held it in 2 quarters.
  • Morgens Waterfall Vintiadis & Co's Elevance Health position peaked at $2.04M in Q1 2019.
  • 1,549 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2022, filed 14 Feb 2023.